CNTB
Price
$0.95
Change
-$0.01 (-1.04%)
Updated
Jun 25, 04:59 PM (EDT)
Capitalization
53.1M
KZR
Price
$4.09
Change
-$0.34 (-7.67%)
Updated
Jun 25, 04:59 PM (EDT)
Capitalization
32.36M
Interact to see
Advertisement

CNTB vs KZR

Header iconCNTB vs KZR Comparison
Open Charts CNTB vs KZRBanner chart's image
Connect Biopharma Holdings
Price$0.95
Change-$0.01 (-1.04%)
Volume$580
Capitalization53.1M
Kezar Life Sciences
Price$4.09
Change-$0.34 (-7.67%)
Volume$2.12K
Capitalization32.36M
CNTB vs KZR Comparison Chart in %
Loading...
CNTB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KZR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CNTB vs. KZR commentary
Jun 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNTB is a Hold and KZR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 26, 2025
Stock price -- (CNTB: $0.96 vs. KZR: $4.43)
Brand notoriety: CNTB and KZR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CNTB: 87% vs. KZR: 180%
Market capitalization -- CNTB: $53.1M vs. KZR: $32.36M
CNTB [@Biotechnology] is valued at $53.1M. KZR’s [@Biotechnology] market capitalization is $32.36M. The market cap for tickers in the [@Biotechnology] industry ranges from $308.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CNTB’s FA Score shows that 0 FA rating(s) are green whileKZR’s FA Score has 0 green FA rating(s).

  • CNTB’s FA Score: 0 green, 5 red.
  • KZR’s FA Score: 0 green, 5 red.
According to our system of comparison, CNTB is a better buy in the long-term than KZR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CNTB’s TA Score shows that 4 TA indicator(s) are bullish while KZR’s TA Score has 4 bullish TA indicator(s).

  • CNTB’s TA Score: 4 bullish, 4 bearish.
  • KZR’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, CNTB is a better buy in the short-term than KZR.

Price Growth

CNTB (@Biotechnology) experienced а -11.51% price change this week, while KZR (@Biotechnology) price change was +8.31% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.95%. For the same industry, the average monthly price growth was +32.23%, and the average quarterly price growth was +16.56%.

Reported Earning Dates

CNTB is expected to report earnings on Mar 31, 2025.

KZR is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (+1.95% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CNTB($53.1M) has a higher market cap than KZR($32.4M). CNTB YTD gains are higher at: -30.746 vs. KZR (-34.077). CNTB has higher annual earnings (EBITDA): -20.6M vs. KZR (-76.06M). KZR has more cash in the bank: 114M vs. CNTB (84M). CNTB has less debt than KZR: CNTB (940K) vs KZR (14.1M). CNTB has higher revenues than KZR: CNTB (26M) vs KZR (0).
CNTBKZRCNTB / KZR
Capitalization53.1M32.4M164%
EBITDA-20.6M-76.06M27%
Gain YTD-30.746-34.07790%
P/E RatioN/AN/A-
Revenue26M0-
Total Cash84M114M74%
Total Debt940K14.1M7%
FUNDAMENTALS RATINGS
KZR: Fundamental Ratings
KZR
OUTLOOK RATING
1..100
14
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
24

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CNTBKZR
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
73%
Momentum
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
89%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
74%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 9 days ago
89%
Bullish Trend 6 days ago
72%
Declines
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 9 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
CNTB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KZR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NMTC0.690.03
+4.80%
NeuroOne Medical Technologies Corp
FIS82.131.63
+2.02%
Fidelity National Information Services
IAC37.120.28
+0.76%
IAC
AOMR9.160.06
+0.66%
Angel Oak Mortgage REIT
BELFA83.11-1.80
-2.12%
Bel Fuse

CNTB and

Correlation & Price change

A.I.dvisor indicates that over the last year, CNTB has been loosely correlated with AMRN. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if CNTB jumps, then AMRN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNTB
1D Price
Change %
CNTB100%
-1.98%
AMRN - CNTB
55%
Loosely correlated
+27.26%
KZR - CNTB
47%
Loosely correlated
+3.99%
ENTA - CNTB
30%
Poorly correlated
+2.81%
BTAI - CNTB
26%
Poorly correlated
+4.85%
VSTM - CNTB
26%
Poorly correlated
-1.30%
More